Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zemplar for secondary hyperparathyroidism in ESRD patients on peritoneal dialysis
NCT00646035Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jan 2002
- Primary completion
- Nov 2002
- Countries
- 2
01
Overview
A Phase 3 trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by Abbott Laboratories. Started Jan 2002; status: completed.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00646035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646035.